$15.2B
$14.8 Million
0.01% of portfolio
598,529
Q3 2024
Reduced 48.39%
$447M
$24,000
0.0% of portfolio
8,779
Q2 2023
Reduced 22.86%
$1.43B
$2.28 Million
0.0% of portfolio
100,892
Q3 2024
Added 124,458.02%
$1.2B
$526,000
0.0% of portfolio
36,434
Q3 2024
Reduced 12.39%
$7.47B
$1.21 Million
0.0% of portfolio
11,254
Q3 2024
Added 13.67%
$0
$0
0.0% of portfolio
34,162
Q3 2024
Added 123.97%
$3.76B
$600,000
0.0% of portfolio
11,376
Q3 2024
Added 13.99%
Abrdn Asia Pacific Inc Fd
-
$0
0.0% of portfolio
-
Q3 2024
New
$3.73B
$1.83 Million
0.0% of portfolio
28,900
Q3 2024
New
$2.43B
$1.76 Million
0.0% of portfolio
75,119
Q3 2024
Reduced 60.05%
$6.53B
$1.64 Million
0.0% of portfolio
32,320
Q3 2024
Added 10.71%
$10.4B
$4.47 Million
0.0% of portfolio
16,238
Q3 2024
Added 341.37%
$797M
$56,000
0.0% of portfolio
11,001
Q3 2024
New
$1.98B
$418,000
0.0% of portfolio
3,151
Q3 2024
Added 23.81%
$1.23B
$9.16 Million
0.0% of portfolio
827,882
Q3 2024
Reduced 23.67%
$6.61B
$2.56 Million
0.0% of portfolio
353,285
Q3 2024
New
$4.15B
$500,000
0.0% of portfolio
6,635
Q3 2024
Added 11.16%
$672M
$1.31 Million
0.0% of portfolio
221,365
Q3 2024
Reduced 9.22%
$2.64B
$409,000
0.0% of portfolio
10,496
Q3 2024
Added 14.65%
$4.38B
$697,000
0.0% of portfolio
6,632
Q3 2024
Added 13.81%
$906M
$158,000
0.0% of portfolio
5,227
Q3 2024
Added 13.66%
$7.23B
$4.37 Million
0.0% of portfolio
24,557
Q3 2024
Added 19.92%
$15.2B
$11.9 Million
0.0% of portfolio
290,817
Q3 2024
Added 86,452.68%
$842M
$3.8 Million
0.0% of portfolio
966,819
Q3 2024
Added 113,376.41%
$3.45B
$615,000
0.0% of portfolio
5,652
Q3 2024
Added 14.34%
$5.31B
$10.6 Million
0.0% of portfolio
1,013,401
Q2 2024
Added 1.32%
$6.14B
$4.14 Million
0.0% of portfolio
54,976
Q3 2024
Reduced 1.68%
$5.68B
$825,000
0.0% of portfolio
18,235
Q3 2024
Reduced 68.84%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 42.37%
-
$0
0.0% of portfolio
-
Q3 2023
Added 42.86%
-
$0
0.0% of portfolio
-
Q3 2024
New
$2.42B
$328,000
0.0% of portfolio
1,826
Q3 2024
Added 15.5%
$3.21B
$653,000
0.0% of portfolio
11,954
Q3 2024
Reduced 2.56%
$6.71B
$1.02 Million
0.0% of portfolio
22,569
Q3 2024
Added 14.06%
$327M
$148,000
0.0% of portfolio
31,790
Q2 2024
Reduced 35.01%
$1.41B
$980,000
0.0% of portfolio
51,078
Q3 2024
Reduced 4.65%
$3.23B
$247,000
0.0% of portfolio
45,498
Q3 2024
Reduced 68.83%
$3.84B
$820,000
0.0% of portfolio
26,014
Q3 2024
Reduced 10.29%
$4.8B
$7.43 Million
0.0% of portfolio
265,466
Q3 2024
Reduced 21.15%
$73.7M
$49,000
0.0% of portfolio
75,686
Q2 2024
Reduced 8.51%
$1.47B
$143,000
0.0% of portfolio
2,613
Q3 2024
Added 29.04%
$4.13B
$1.36 Million
0.0% of portfolio
58,347
Q3 2024
Reduced 91.91%
$15.9B
$11.2 Million
0.0% of portfolio
185,134
Q3 2024
Reduced 0.46%
$11.5B
$4.43 Million
0.0% of portfolio
46,142
Q3 2024
Added 11,321.29%
$362M
$22,000
0.0% of portfolio
8,011
Q2 2024
New
$51.2M
$36,000
0.0% of portfolio
45,448
Q3 2024
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 16.97%
$5.5B
$695,000
0.0% of portfolio
7,281
Q3 2024
Reduced 0.93%
$2.96B
$135,000
0.0% of portfolio
11,357
Q3 2024
Added 69.51%